Diurnal's £11m Placing To Promote First Product Launch And Pipeline
Diurnal's CEO Martin Whitaker says 2018 promises to be transformational for the late-stage endocrinology company.
Diurnal's CEO Martin Whitaker says 2018 promises to be transformational for the late-stage endocrinology company.